Ding J, Zhang Y, Che Y. Ovarian cancer stem cells: critical roles in anti-tumor immunity. Front Genet. 2022;13:998220.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajtak A, Ostrowska-Leśko M, Żak K, Tarkowski R, Kotarski J, Okła K. Integration of local and systemic immunity in ovarian cancer: implications for immunotherapy. Front Immunol. 2022;13:1018256.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qiu Y, Chen Y, Agbede O, Eshaghi E, Peng C. Circular RNAs in epithelial ovarian Cancer: from biomarkers to therapeutic targets. Cancers. 2022;14(22):5711.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kharitonenkov A, Adams AC. Inventing new medicines: the FGF21 story. Mol Metabolism. 2013;3(3):221–9.

Article  Google Scholar 

Ardizzone A, Scuderi SA, Giuffrida D, Colarossi C, Puglisi C, Campolo M, Cuzzocrea S, Esposito E, Paterniti I. Role of fibroblast growth factors receptors (FGFRs) in brain tumors, Focus on Astrocytoma and Glioblastoma. Cancers. 2020;12(12):3825.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov. 2009;8(3):235–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Farooq M, Khan AW, Kim MS, Choi S. The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration. Cells. 2021;10(11):3242.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Presta M, Chiodelli P, Giacomini A, Rusnati M, Ronca R. Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach. Pharmacol Ther. 2017;179:171–87.

Article  CAS  PubMed  Google Scholar 

Rosen A, Sevelda P, Klein M, Dobianer K, Hruza C, Czerwenka K, Hanak H, Vavra N, Salzer H, Leodolter S. First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. Br J Cancer. 1993;67(5):1122–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shang A, Zhou C, Bian G, Chen W, Lu W, Wang W, Li D. Mir-381-3p restrains cervical cancer progression by downregulating FGF7. J Cell Biochem. 2019;120(1):778–89.

Article  CAS  PubMed  Google Scholar 

Shaoul R, Eliahu L, Sher I, Hamlet Y, Miselevich I, Goldshmidt O, Ron D. Elevated expression of FGF7 protein is common in human gastric diseases. Biochem Biophys Res Commun. 2006;350(4):825–33.

Article  CAS  PubMed  Google Scholar 

Yang C, Song D, Zhao F, et al. Comprehensive analysis of the prognostic value and immune infiltration of FGFR family members in gastric cancer. Front Oncol. 2022;12:936952. https://doi.org/10.3389/fonc.2022.936952.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacquemier J, Sun ZZ, Penault-Llorca F, Geneix J, Devilard E, Adélaïde J, Birnbaum D. FGF7 protein expression in human breast carcinomas. J Pathol. 1998;186(3):269–74.

Article  CAS  PubMed  Google Scholar 

Xu FF, Xie WF, Zha GQ, Chen HW, Deng L. MiR-520f promotes cell aggressiveness by regulating fibroblast growth factor 16 in hepatocellular carcinoma. Oncotarget. 2017;8(65):109546–58.

Article  PubMed  PubMed Central  Google Scholar 

He W, Liu X, Luo Z, Li L, Fang X. FGF16 regulated by miR-520b enhances the cell proliferation of lung cancer. Open Med (Warsaw Poland). 2021;16(1):419–27.

Article  CAS  Google Scholar 

Shimokawa T, Furukawa Y, Sakai M, Li M, Miwa N, Lin YM, Nakamura Y. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. Cancer Res. 2003;63(19):6116–20.

CAS  PubMed  Google Scholar 

Ling Y, Du Q. FGF10/FGF17 as prognostic and drug response markers in acute myeloid leukemia. Curr Res Translational Med. 2022;70(1):103316.

Article  CAS  Google Scholar 

Itoh N, Ornitz DM. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J BioChem. 2011;149(2):121–30.

Article  CAS  PubMed  Google Scholar 

Katoh M. Therapeutics targeting FGF Signaling Network in Human diseases. Trends Pharmacol Sci. 2016;37(12):1081–96.

Article  CAS  PubMed  Google Scholar 

Bai YP, Shang K, Chen H, Ding F, Wang Z, Liang C, Xu Y, Sun MH, Li YY. FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7. Cancer Sci. 2015;106(10):1278–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tovar V, Cornella H, Moeini A, Vidal S, Hoshida Y, Sia D, Peix J, Cabellos L, Alsinet C, Torrecilla S, et al. Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma. Gut. 2017;66(3):530–40.

Article  CAS  PubMed  Google Scholar 

Hu L, Cong L. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer. Oncol Rep. 2015;34(5):2683–91.

Article  CAS  PubMed  Google Scholar 

Tebben PJ, Kalli KR, Cliby WA, Hartmann LC, Grande JP, Singh RJ, Kumar R. (2005). Elevated fibroblast growth factor 23 in women with malignant ovarian tumors. Mayo Clinic proceedings, 80(6), 745–751.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thul PJ, Åkesson L, Wiking M, Mahdessian D, Geladaki A, Blal A, Alm H, Asplund T, Björk A, Breckels L, L. M., et al. A subcellular map of the human proteome. Volume 356. Science; 2017. p. eaal3321. (New York, N.Y.). 6340.

Koch A, Jeschke J, Van Criekinge W, van Engeland M, De Meyer T. MEXPRESS update 2019. Nucleic Acids Res. 2019;47(W1):W561–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Győrffy B. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J. 2021;19:4101–9.

Article  PubMed  PubMed Central  Google Scholar 

Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT et al. (2010). The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res, 38(Web Server issue), W214–20.

Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–13.

Article  CAS  PubMed  Google Scholar 

Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.Cancer discovery,2(5), 401–404.

Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.

Article  PubMed  PubMed Central  Google Scholar 

Martens M, Ammar A, Riutta A, Waagmeester A, Slenter DN, Hanspers K, Miller A, Digles R, Lopes D, Ehrhart EN, F., et al. WikiPathways: connecting communities. Nucleic Acids Res. 2021;49(D1):D613–21.

Article  CAS  PubMed  Google Scholar 

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: a web server for Comprehensive Analysis of Tumor-infiltrating Immune cells. Cancer Res. 2017;77(21):e108–10.

Article